Loading...
Header Logo
Keywords
Last Name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Kimberly Lenz and Paul Jeffrey.

 
Connection Strength
 
 
 
2.457
 
  1. Jeffrey PL, Lenz K. The opiate dilemma. J Manag Care Spec Pharm. 2014 May; 20(5):437-8.
    View in: PubMed
    Score: 0.689
  2. Garcia MM, Lenz K, Greenwood BC, Angelini MC, Thompson T, Clements KM, Mauro RP, Jeffrey PL. Impact of Sequential Opioid Dose Reduction Interventions in a State Medicaid Program between 2002 and 2017. J Pain. 2019 Jan 25.
    View in: PubMed
    Score: 0.239
  3. Chiara AN, Kashalikar N, Pomfret TC, Lenz K, Faber DM, Goldstein J, Clements KM, Angelini MC, Leto P, Jeffrey PL. An Evaluation of a Multidisciplinary Pediatric Behavioral Health Medication Initiative Workgroup's Interventions on Medication Prescribing in a Population of Medicaid Patients. J Manag Care Spec Pharm. 2018 Aug; 24(8):746-751.
    View in: PubMed
    Score: 0.231
  4. Kouris G, Hydery T, Greenwood BC, Lavitas P, Price M, Clements K, Alper CJ, Lenz K, Jeffrey PL. Effectiveness of Ledipasvir/Sofosbuvir and Predictors of Treatment Failure in Members with Hepatitis C Genotype 1 Infection: A Retrospective Cohort Study in a Medicaid Population. J Manag Care Spec Pharm. 2018 Jul; 24(7):591-597.
    View in: PubMed
    Score: 0.230
  5. Hydery T, Price MK, Greenwood BC, Takeshita M, Kunte PS, Mauro RP, Lenz K, Jeffrey PL. Evaluation of Progesterone Utilization and Birth Outcomes in a State Medicaid Plan. Pharmacotherapy. 2017 Oct; 37(10):1328-1334.
    View in: PubMed
    Score: 0.218
  6. Tran S, Lavitas P, Stevens K, Greenwood BC, Clements K, Alper CJ, Lenz K, Price M, Hydery T, Arnold JL, Takeshita M, Bacon R, Peristere JP, Jeffrey PL. The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid Population. J Manag Care Spec Pharm. 2017 May; 23(5):532-539.
    View in: PubMed
    Score: 0.212
  7. Lavitas P, Tesell M, Hydery T, Greenwood BC, Price M, Lenz K, Jeffrey P. Overview of Comprehensive Hepatitis C Virus Medication Management in a State Medicaid Program. J Manag Care Spec Pharm. 2016 Oct; 22(10):1161-6.
    View in: PubMed
    Score: 0.204
  8. Clements KM, Clark RE, Lavitas P, Kunte P, Graham CS, O'Connell E, Lenz K, Jeffrey P. Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study. J Manag Care Spec Pharm. 2016 Jun; 22(6):714-722b.
    View in: PubMed
    Score: 0.199
  9. Garcia MM, Angelini MC, Thomas T, Lenz K, Jeffrey P. Implementation of an opioid management initiative by a state Medicaid program. J Manag Care Spec Pharm. 2014 May; 20(5):447-54.
    View in: PubMed
    Score: 0.172
  10. Tesell MA, Alper CJ, Bacon R, Greenwood BC, Lenz K, Jeffrey PL, Stevens K. Effect of Lumacaftor/Ivacaftor on Pulmonary Exacerbation Rates in Members with Cystic Fibrosis in a Medicaid Population. J Manag Care Spec Pharm. 2019 Sep; 25(9):1021-1025.
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.